Compounds > 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate
Page last updated: 2024-11-05

8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate and Hepatocellular Carcinoma

8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate has been researched along with Hepatocellular Carcinoma in 2 studies

8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate: intracellular calcium antagonist; RN given refers to parent cpd

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Banfi, C1
Mussoni, L1
Risé, P1
Cattaneo, MG1
Vicentini, L1
Battaini, F1
Galli, C1
Tremoli, E1
Gong, G1
Waris, G1
Tanveer, R1
Siddiqui, A1

Other Studies

2 other studies available for 8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate and Hepatocellular Carcinoma

ArticleYear
Very low density lipoprotein-mediated signal transduction and plasminogen activator inhibitor type 1 in cultured HepG2 cells.
    Circulation research, 1999, Jul-23, Volume: 85, Issue:2

    Topics: Antioxidants; Arachidonic Acid; Calcium Channel Blockers; Calcium-Calmodulin-Dependent Protein Kinas

1999
Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B.
    Proceedings of the National Academy of Sciences of the United States of America, 2001, Aug-14, Volume: 98, Issue:17

    Topics: Acetylcysteine; Antioxidants; Calcium; Calcium Signaling; Carcinoma, Hepatocellular; Chelating Agent

2001